InvestorsHub Logo
Followers 9
Posts 157
Boards Moderated 0
Alias Born 01/31/2014

Re: None

Monday, 08/31/2015 9:23:46 AM

Monday, August 31, 2015 9:23:46 AM

Post# of 1350
NEWS - Perseon Announces the Initiation of the First Multi-Organ in vivo Ablation Zone Study for MicroThermX(R) in Laparoscopic and Open Approaches

http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-newsArticle&ID=2083224


"This trial is pivotal for Perseon, as it marks the first in vivo trial of its kind for MicroThermX," said Brian A. Meltzer, Chief Medical Officer of Perseon. "The push for real world results reinforces our commitment to clinically relevant data and further shows how our Synchronous Wave Alignment Technology provides added efficiency for physicians in the field of energy ablation."



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.